Release Date: 11/02/09 08:27 Summary: Response to ASX Query - Appendix 5B Price Sensitive: Yes Download Document 62.33KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%